Global radiopharmaceuticals market set to grow to $21.9 billion by 2029 with 16.4% CAGR.

From GlobeNewswire: 2025-06-17 14:02:00

The global radiopharmaceuticals market is set to grow from $10.3 billion in 2024 to $21.9 billion by 2029, with a CAGR of 16.4%. The report covers market dynamics, drivers, and trends, highlighting the role of radiopharmaceuticals in healthcare. Key factors driving market growth include rising cancer prevalence, unmet needs in oncology, and advances in nuclear imaging technologies.

Emerging startups in the field include Actinium Pharmaceuticals Inc., developing targeted radiotherapies, and RadioMedix, focusing on PET imaging and therapeutic radiopharmaceuticals. The report projects the market to reach $21.9 billion by 2029, with oncology remaining the dominant application segment. The therapeutic radiopharmaceuticals segment is expected to exhibit the fastest growth.

Leading companies in the radiopharmaceuticals market include Bayer AG, Blue Earth Diagnostics, and Boston Scientific Corp. BCC Research offers custom research reports to provide insights for informed decision-making. Special offer: 30% off any BCC Research report for a limited time. Purchase a copy of the report directly from BCC Research.

For media inquiries or to access the market research library, contact [email protected]. BCC Research offers objective, unbiased market research reports to help businesses make informed decisions. Data and analysis from this press release must be credited to BCC Research LLC as the source and publisher.



Read more at GlobeNewswire: Radiopharmaceuticals Market Set to Grow with 16.4% CAGR